Cited In for PMID: 30382794

Year	Number of Results
2018	1
2020	1
2021	3
2022	1
2023	1
2025	2
2026	0

1

Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients.

Gleser MA, Zettner EM. Gleser MA, et al. Int J Audiol. 2018 Dec;57(12):917-924. doi: 10.1080/14992027.2018.1514537. Epub 2018 Nov 1. Int J Audiol. 2018. PMID: 30382794

2

Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project.

Cheong J, Boreland S, Shattock E, Bowman E, Belkarty B, Jones A, Felton I, Ukor EF, Stowell J, Jose RJ, Madge S, Wilkins J, Frost E, Premachandra P, Loebinger M, Simmonds NJ, Drobniewski F, Shah A. Cheong J, et al. BMJ Open Qual. 2025 Apr 15;14(2):e002847. doi: 10.1136/bmjoq-2024-002847. BMJ Open Qual. 2025. PMID: 40233985 Free PMC article.

3

Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension).

Schneider-Futschik EK, Munro CB, Quinlan C, Ranganathan S. Schneider-Futschik EK, et al. Pediatr Pulmonol. 2025 Feb;60(2):e27505. doi: 10.1002/ppul.27505. Pediatr Pulmonol. 2025. PMID: 39935234 Free PMC article.

4

Clinical Observations in Patients With Cystic Fibrosis-Related Diabetes and Self-Reported Ototoxicity Symptoms.

Nichols N, Rubenstein RC, Kelly A, Vachhani JJ, Echaluse MV, Garinis AC. Nichols N, et al. Am J Audiol. 2023 Nov 28;33(1):1-9. doi: 10.1044/2023_AJA-22-00237. Online ahead of print. Am J Audiol. 2023. PMID: 38016170 Free PMC article.

5

Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.

Kimple AJ, Senior BA, Naureckas ET, Gudis DA, Meyer T, Hempstead SE, Resnick HE, Albon D, Barfield W, Benoit MM, Beswick DM, Callard E, Cofer S, Downer V, Elson EC, Garinis A, Halderman A, Hamburger L, Helmick M, McCown M, McKinzie CJ, Phan H, Rodriguez K, Rubenstein RC, Severin A, Shah G, Shenoy A, Sprouse B, Virgin F, Woodworth BA, Lee SE. Kimple AJ, et al. Int Forum Allergy Rhinol. 2022 Sep;12(9):1089-1103. doi: 10.1002/alr.22974. Epub 2022 Feb 22. Int Forum Allergy Rhinol. 2022. PMID: 35089650 Free PMC article.

6

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.

Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.

7

Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides.

Huang SP, McKinzie CJ, Tak CR. Huang SP, et al. J Manag Care Spec Pharm. 2021 Feb;27(2):157-165. doi: 10.18553/jmcp.2021.27.2.157. J Manag Care Spec Pharm. 2021. PMID: 33506732 Free PMC article.

8

Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.

Garinis A, Gleser M, Johns A, Larsen E, Vachhani J. Garinis A, et al. J Cyst Fibros. 2021 Mar;20(2):278-283. doi: 10.1016/j.jcf.2020.07.001. Epub 2020 Jul 24. J Cyst Fibros. 2021. PMID: 32713806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 30382794

8 results

Results by year